Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-060218

Chief Financial Officer bought 1,500 shares at $7.04 ($10,560)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-11-10 Purchase : show line 1 in the form +1,500 $7.04 $10,560 340,910 D
Open-market purchases · 1,500 sh · avg $7.04 · $10,560
Loading xslF345X03/doc4.xml…